Validation of HbA1c of 6.5% for diagnosing diabetes mellitus via the use of taxometric analysis

Ann Epidemiol. 2012 Jan;22(1):66-9. doi: 10.1016/j.annepidem.2011.10.002. Epub 2011 Nov 9.

Abstract

Purpose: Previous studies in which authors examined the internal and external validity of a glycemic cut-point for diagnosis of diabetes mellitus have provided mixed results. The purpose of the current study was to test the internal validity of the HbA1c 6.5% cut-point with taxometric analysis.

Methods: Data on 14,798 participants were obtained from the National Health and Nutrition Examination Survey, years 1999-2008. Fasting plasma glucose and HbA1c were submitted to the taxometric procedures MAMBAC (mean above minus below a cut) and MAXSLOPE (MAXimum SLOPE). The comparison curve fit index was the outcome measure, with values less than 0.40 and greater than 0.60 indicative of dimensional and categorical solutions, respectively.

Results: In the full sample, MAXSLOPE and MAMBAC procedures yielded CCFIs of 0.778 and 0.872, respectively. Analyses were repeated in subgroups by age, sex, fasting insulin level, ethnicity, and year; the lowest comparison curve fit index measurement from any analysis was 0.706.

Conclusions: These results support a categorical overdimensional model of diabetes, consistent with the new HbA1c cut-point recommendation.

Publication types

  • Validation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Glucose / analysis
  • Chi-Square Distribution
  • Child
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / diagnosis*
  • Factor Analysis, Statistical
  • Female
  • Glycated Hemoglobin / analysis*
  • Humans
  • Male
  • Middle Aged
  • Nutrition Surveys
  • Software

Substances

  • Blood Glucose
  • Glycated Hemoglobin A